EVALUATION OF SOME BLOOD PARAMETERS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA PATIENTS IN IRAQ

Main Article Content

Sarah Musa Essa, Abdul-Hadi Abbas Hadi

Abstract

Abstract

Acute myeloid leukemia (AML) is a type of leukemias that begins in the bone marrow and has the potential to metastasize to several organs. The study aimed to assess the changes in some serum biomarkers in Iraqi individuals with AML and explore their role in disease progression. The current investigation comprised 100 individuals (males and females): 50 diagnosed with AML and a control group of 50 healthy participants. Blood samples were taken from AML patients and healthy individuals to evaluate the serum levels of certain biomarkers. The following parameters have been studied: estimation the indicators of liver [alanine aminotransferase (ALT), aspartate aminotransferase (AST)], and kidney functions (urea and creatinine); assessment of lipid profile [total cholesterol (TC) and triglycerides (TG)]; evaluation of some hematological parameters such as erythrocytes (RBCs), hemoglobin (Hb), hematocrit (HCT), leukocytes (WBCs), and thrombocytes (platelets). This study emphasizes the role biomarkers play in AML prediction and suggests that early detection is essential to improving patient survival rates and developing successful treatment plans.


 

Article Details

How to Cite
Abdul-Hadi Abbas Hadi, S. M. E. (2024). EVALUATION OF SOME BLOOD PARAMETERS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA PATIENTS IN IRAQ. Obstetrics and Gynaecology Forum, 34(3s), 2215–2219. Retrieved from https://obstetricsandgynaecologyforum.com/index.php/ogf/article/view/658
Section
Articles

Similar Articles

1 2 3 4 5 6 7 8 > >> 

You may also start an advanced similarity search for this article.